Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report.

Cippà PE, Gaspert A, Etter C, Guenduez Z, Ferrari-Lacraz S, Rüsi B, Fehr T.

Hum Immunol. 2014 May;75(5):462-5. doi: 10.1016/j.humimm.2014.02.008. Epub 2014 Feb 12.

PMID:
24530822
2.

Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation.

Thaunat O, Hanf W, Dubois V, McGregor B, Perrat G, Chauvet C, Touraine JL, Morelon E.

Transpl Immunol. 2009 Mar;20(4):209-11. doi: 10.1016/j.trim.2008.12.006. Epub 2009 Jan 21.

PMID:
19166936
3.

Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation.

Jolly EC, Key T, Rasheed H, Morgan H, Butler A, Pritchard N, Taylor CJ, Clatworthy MR.

Am J Transplant. 2012 Oct;12(10):2845-8. doi: 10.1111/j.1600-6143.2012.04172.x. Epub 2012 Jul 3.

4.

Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation.

Goral S, Prak EL, Kearns J, Bloom RD, Pierce E, Doyle A, Grossman R, Naji A, Kamoun M.

Nephrol Dial Transplant. 2008 Jan;23(1):390-2. Epub 2007 Oct 23. No abstract available.

PMID:
17956891
5.

Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.

Mierzejewska B, Schroder PM, Baum CE, Blair A, Smith C, Duquesnoy RJ, Marrari M, Gohara A, Malhotra D, Kaw D, Liwski R, Rees MA, Stepkowski S.

Hum Immunol. 2014 Aug;75(8):703-8. doi: 10.1016/j.humimm.2014.04.001. Epub 2014 Apr 19.

6.

HLA-DP antibodies before and after renal transplantation.

Billen EV, Christiaans MH, Doxiadis II, Voorter CE, van den Berg-Loonen EM.

Tissue Antigens. 2010 Mar;75(3):278-85. doi: 10.1111/j.1399-0039.2009.01428.x. Epub 2010 Jan 11.

PMID:
20070601
7.

Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.

Cross AR, Lion J, Loiseau P, Charron D, Taupin JL, Glotz D, Mooney N.

Hum Immunol. 2016 Nov;77(11):1092-1100. doi: 10.1016/j.humimm.2016.04.003. Epub 2016 Apr 6. Review.

PMID:
27060781
8.

Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.

Aguilera I, Alvarez-Marquez A, Gentil MA, Fernandez-Alonso J, Fijo J, Saez C, Wichmann I, Nuñez-Roldan A.

Nephrol Dial Transplant. 2008 Jul;23(7):2393-8. doi: 10.1093/ndt/gfm955. Epub 2008 Feb 28.

PMID:
18308775
9.

HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.

Bosch A, Llorente S, Eguia J, Mrowiec A, Boix F, López-Hernández R, Campillo JA, Salgado G, Moya-Quiles MR, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Hum Immunol. 2014 Apr;75(4):338-41. doi: 10.1016/j.humimm.2014.01.010. Epub 2014 Jan 30.

PMID:
24486575
10.

Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival.

Redondo-Pachón D, Pascual J, Pérez-Sáez MJ, García C, Hernández JJ, Gimeno J, Mir M, Crespo M.

Transpl Immunol. 2016 Feb;34:1-7. doi: 10.1016/j.trim.2015.11.002. Epub 2015 Nov 18.

PMID:
26603314
11.

Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations.

Dieplinger G, Ditt V, Arns W, Huppertz A, Kisner T, Hellmich M, Bauerfeind U, Stippel DL.

Transpl Int. 2014 Jan;27(1):60-8. doi: 10.1111/tri.12207. Epub 2013 Nov 14.

12.

Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.

Wiebe C, Pochinco D, Blydt-Hansen TD, Ho J, Birk PE, Karpinski M, Goldberg A, Storsley LJ, Gibson IW, Rush DN, Nickerson PW.

Am J Transplant. 2013 Dec;13(12):3114-22. doi: 10.1111/ajt.12478. Epub 2013 Oct 25.

13.

Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.

Caro-Oleas JL, González-Escribano MF, Gentil-Govantes MÁ, Acevedo MJ, González-Roncero FM, Blanco GB, Núñez-Roldán A.

Transplantation. 2012 Aug 27;94(4):338-44. doi: 10.1097/TP.0b013e31825ace2c.

PMID:
22814330
14.

Acute humoral rejection in a zero mismatch deceased donor renal transplant due to an antibody to an HLA-DP alpha.

Singh P, Colombe BW, Francos GC, Martinez Cantarin MP, Frank AM.

Transplantation. 2010 Jul 27;90(2):220-1. doi: 10.1097/TP.0b013e3181e1177d. No abstract available.

PMID:
20644454
15.

Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.

Ginevri F, Nocera A, Comoli P, Innocente A, Cioni M, Parodi A, Fontana I, Magnasco A, Nocco A, Tagliamacco A, Sementa A, Ceriolo P, Ghio L, Zecca M, Cardillo M, Garibotto G, Ghiggeri GM, Poli F.

Am J Transplant. 2012 Dec;12(12):3355-62. doi: 10.1111/j.1600-6143.2012.04251.x. Epub 2012 Sep 7.

16.
17.

C4d-positive acute antibody-mediated rejection due to anti-HLA-DP antibody: a tale of one patient and a review of the University of Wisconsin experience.

Samaniego M, Mezrich J, Torrealba J, Lorentzen D, Schadde E, Djamali A, Zachariah M, Sollinger H, Pirsch J.

Clin Transpl. 2006:503-7. No abstract available.

PMID:
18365412
18.

HLA-DP antibodies in patients awaiting renal transplantation.

Pfeiffer K, Vögeler U, Albrecht KH, Eigler FW, Buchholz B, Grosse-Wilde H.

Transpl Int. 1995;8(3):180-4.

PMID:
7626176
19.

Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.

Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.

Transplantation. 2009 Jan 15;87(1):94-9. doi: 10.1097/TP.0b013e31818bd790.

PMID:
19136897
20.

De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.

Willicombe M, Brookes P, Sergeant R, Santos-Nunez E, Steggar C, Galliford J, McLean A, Cook TH, Cairns T, Roufosse C, Taube D.

Transplantation. 2012 Jul 27;94(2):172-7. doi: 10.1097/TP.0b013e3182543950.

PMID:
22735711

Supplemental Content

Support Center